Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 5/2005

01-10-2005

Ask the Editor

Auteur: Christopher J. McDougle

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 5/2005

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Excerpt

I am the parent of a 14-year-old young man with autism and a moderate degree of mental retardation. He is in the eighth grade in a self-contained classroom. He has a number of rituals that he engages in that appear to interfere with his quality of life. For example, he seems to have the need to walk throughout the house to make certain that all of the doors to the rooms and cabinets are closed and that the drawers in the kitchen and on various pieces of furniture are shut. Once he has done this, he still has difficulty relaxing and being with the family; he appears to have to go back through the house repeatedly to check to be certain that the doors and drawers have remained closed, even though he did a very thorough job the first time around. Our pediatrician diagnosed him with obsessive-compulsive disorder (OCD) and suggested that we consider a medicine to treat these behaviors. What do you think? …
Literatuur
go back to reference Gordon C.T., State R.C., Nelson J.E., Hamburger S.D., Rapoport J.L., (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder Archives of General Psychiatry 50:441–447PubMed Gordon C.T., State R.C., Nelson J.E., Hamburger S.D., Rapoport J.L., (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder Archives of General Psychiatry 50:441–447PubMed
go back to reference Hollander E., Phillips A., Chaplin W., Zagursky K., Novotny S., Wasserman S., Iyengar R., (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism Neuropsychopharmacology 30:582–589PubMedCrossRef Hollander E., Phillips A., Chaplin W., Zagursky K., Novotny S., Wasserman S., Iyengar R., (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism Neuropsychopharmacology 30:582–589PubMedCrossRef
go back to reference McDougle C.J., Kresch L.E., Posey D.J., (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors Journal of Autism and Developmental Disorders 30(5):427–435PubMedCrossRef McDougle C.J., Kresch L.E., Posey D.J., (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors Journal of Autism and Developmental Disorders 30(5):427–435PubMedCrossRef
go back to reference McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H., (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Archives of General Psychiaty 53:1001–1008 McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H., (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Archives of General Psychiaty 53:1001–1008
go back to reference McDougle C.J., Scahill L., Aman M.G., McCracken J.T., Tierney E., Davies M., Arnold L.E., Posey D.J., Martin A., Ghuman J.K., Shah B., Chuang S.Z., Swiezy N.B., Gonzalez N.M., Hollway J., Koenig K., McGough J.J., Ritz L., Vitiello B., (in press) Risperidone for the core symptom domains of autism: Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry 162:1142–1148PubMedCrossRef McDougle C.J., Scahill L., Aman M.G., McCracken J.T., Tierney E., Davies M., Arnold L.E., Posey D.J., Martin A., Ghuman J.K., Shah B., Chuang S.Z., Swiezy N.B., Gonzalez N.M., Hollway J., Koenig K., McGough J.J., Ritz L., Vitiello B., (in press) Risperidone for the core symptom domains of autism: Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry 162:1142–1148PubMedCrossRef
go back to reference Research Units on Pediatric Psychopharmacology Autism Network (2002). Risperidone in children with autism and serious behavioral problems New England Journal of Medicine 347(5):314–321 Research Units on Pediatric Psychopharmacology Autism Network (2002). Risperidone in children with autism and serious behavioral problems New England Journal of Medicine 347(5):314–321
Metagegevens
Titel
Ask the Editor
Auteur
Christopher J. McDougle
Publicatiedatum
01-10-2005
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 5/2005
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-005-0013-x

Andere artikelen Uitgave 5/2005

Journal of Autism and Developmental Disorders 5/2005 Naar de uitgave